688351 微电生理
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.2172.8833.0390.3390.271
总资产报酬率 ROA (%)1.9902.6292.8020.3150.250
投入资产回报率 ROIC (%)2.1482.8022.9650.3310.264

边际利润分析
销售毛利率 (%)55.76957.97558.72963.51269.106
营业利润率 (%)14.71811.51313.1972.3231.162
息税前利润/营业总收入 (%)16.70610.41511.887-0.108-2.564
净利润/营业总收入 (%)14.56410.99712.6031.7281.180

收益指标分析
经营活动净收益/利润总额(%)18.62754.86422.310-510.112-196.339
价值变动净收益/利润总额(%)67.75529.97439.163397.91536.306
营业外收支净额/利润总额(%)-1.247-4.169-4.603-36.285-1.805

偿债能力分析
流动比率 (X)8.3579.77514.57015.75424.117
速动比率 (X)7.2698.77213.39014.48522.803
资产负债率 (%)10.9309.5818.0247.5806.519
带息债务/全部投入资本 (%)1.2581.3110.110-0.094-0.657
股东权益/带息债务 (%)7,695.5027,393.62988,802.928-103,502.962-14,867.720
股东权益/负债合计 (%)814.932943.6981,146.2791,219.1981,433.986
利息保障倍数 (X)7.700-16.335-16.3120.0600.692

营运能力分析
应收账款周转天数 (天)57.25958.87856.16849.70243.082
存货周转天数 (天)267.905264.808264.136313.741295.355